Introduction {#s1}
============

The specification of different cell fates by morphogen gradients has been a longstanding focus within developmental biology. While it is well established that gradients of diffusible morphogens produce complex pattern during development, their role as drivers of morphological evolution has mostly been inferred from theoretical studies, due to the challenge of quantifying and functionally assessing their activities in species outside of select genetic model organisms ([@bib30]; [@bib13]; [@bib11]; [@bib16]). Bone Morphogenetic Proteins (BMPs) pattern the embryonic dorsal-ventral axis of bilaterian embryos, raising the question of the role of the BMP gradient in the evolution of body plans ([@bib2]). To address this question, we compared the functions of embryonic BMP gradients in two fly species that differ in tissue complexity downstream of BMP signaling.

In *Drosophila melanogaster* embryos, the BMP gradient forms through directed extracellular BMP movement and initiates a positive feedback circuit leading to a bistable pattern of BMP signaling by the end of the blastoderm stage (reviewed in [@bib19]; [@bib28]; [@bib33]). High levels of BMP signaling, centered on the dorsal midline, specify a single extraembryonic tissue, the amnioserosa. However, in basal-branching flies, including *Megaselia abdita* (Phoridae), BMP signaling specifies two extraembryonic tissues, the serosa and the amnion ([@bib25]). Previously, we showed that the dynamics of BMP signaling in the blastoderm are similar between *Megaselia* and *Drosophila*, but differ in the early gastrula when the *Megaselia* gradient broadens while the *Drosophila* gradient remains static ([@bib23]). Here, we show that differences in the control of a positive feedback circuit involving *eiger* (*egr*) ([@bib9]) are responsible for the altered dynamics of BMP signaling and amnion specification in *Megaselia*. We hereby reveal an evolutionary mechanism by which morphogen gradients can alter the complexity of tissue types between species.

Results and discussion {#s2}
======================

BMP signaling during gastrulation is necessary and sufficient for amnion specification {#s2-1}
--------------------------------------------------------------------------------------

In *Megaselia* and *Drosophila*, BMP signaling specifies extraembryonic membranes ([Figure 1A](#fig1){ref-type="fig"}) and can be quantified by staining with an antibody specific to the activated phosphorylated form of Mad (pMad), an essential transcriptional effector of the BMP pathway ([@bib7]). During early blastoderm stages in both species BMP signaling is initially low and broadly distributed over the dorsal regions of the embryo but refines into a narrow dorsal stripe of high activity by the onset of gastrulation. However, during early gastrulation in *Megaselia*, the BMP signaling domain broadens to encompass the edge of the germ rudiment comprising the presumptive amnion, while the domain in *Drosophila* remains static ([Figure 1B](#fig1){ref-type="fig"}).10.7554/eLife.20894.002Figure 1.Extraembryonic tissue and BMP signaling differ between *Megaselia* and *Drosophila*.(**A**) Schematics of *Megaselia* embryos with serosa and amnion and of *Drosophila* embryos with amnioserosa at the beginning of gastrulation (stage 6, left) and during early germ band retraction (stage 12, right), modified from [@bib23]. Here, as in all subsequent figures, blastoderm and gastrula stages are shown in dorsal view while later stages are shown in lateral view with the dorsal side up unless specified otherwise. Anterior is always left. (**B**) Schematic pMad intensity profiles at the dorsal midline relative to prospective serosa (S, red), amnion (A, blue), amnioserosa (AS, maroon), and embryonic tissues (E, grey) in *Megaselia* and *Drosophila*. Representative embryos stained for pMad on right.**DOI:** [http://dx.doi.org/10.7554/eLife.20894.002](10.7554/eLife.20894.002)

In *Megaselia*, serosa and amnion specification can be visualized with a combination of genetic markers. A homolog of *zerknüllt* (*Mab-zen*), which encodes a homeodomain protein, marks and specifies serosa cells in blastoderm (stage 5) and gastrula embryos (stage 6) ([@bib20]). Homologs of *hindsight* (*Mab-hnt*) and *dorsocross* (*Mab-doc*, *Mab-doc2*) ([Figure 2A](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}), which encode zinc-finger and T-box proteins respectively, are also expressed in stage 5 and 6 embryos in a slightly wider domain than *Mab-zen* ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}) ([@bib23]), encompassing both the prospective serosa and amnion. Lastly, a homolog of the TNF alpha gene *eiger* (*Mab-egr*) is expressed in the serosa and amnion of gastrulating *Megaselia* embryos ([Figure 2B--C](#fig2){ref-type="fig"}). *Mab-egr* expression continues until dorsal closure, but from germ band extension (stage 11) onwards it is expressed only in the amnion cells, which at this stage are polyploid and much larger than the adjacent embryonic cells ([Figure 2D--E](#fig2){ref-type="fig"} and [Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}). The time course of serosa and amnion specification is suggested by the dorsal repression of an embryonic marker, *Megaselia even-skipped* (*Mab-eve*) ([@bib23]). In wild-type blastoderm embryos, the repression of *Mab-eve* extends laterally from the dorsal midline to the boundary of the *Mab-zen* domain, but after gastrulation begins *Mab-eve* expression withdraws further to abut the *Mab-doc/hnt* domain ([Figure 2F--G](#fig2){ref-type="fig"} and [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}), likely as a result of repression by BMP signaling. Conversely, overexpression of *Mab-eve* suppresses *Mab-zen* expression ([Figure 2---figure supplement 4](#fig2s4){ref-type="fig"}). Thus, amnion specification might not be completed before the onset of gastrulation. At stage 6, the amnion anlage of *Megaselia* is defined as the thin band of cells expressing *Mab-doc/doc2*, *Mab-hnt*, and *Mab-egr* but not *Mab-zen* while, after germ band extension, mature amnion cells are defined by their large size and *Mab-egr* expression.10.7554/eLife.20894.003Figure 2.Specification of amnion by BMP signaling in *Megaselia*.(**A**) *Mab-hnt* and *Mab-doc* expression at the late blastoderm stage. Scale bar = 100 µm. (**B**, **C**) *Mab-egr* and *Mab-zen* (**B**) and *Mab-egr* and *Mab-doc* (**C**) expression at early gastrulation. (**D**) *Mab-egr* and *Mab-zen* expression after germ band extension. Asterisks denote tears in the serosa during sample preparation. (**E**) *Mab-egr* expression during germ band retraction. The serosa has been removed and nuclei have been labeled with DAPI. Boxed region enlarged (**E'--E''**). (**F**, **G**) *Mab-doc, Mab-zen* and *Mab-eve* expression at late blastoderm stage (stage 5) (**F**, enlargement **F'**) and early gastrulation (stage 6) (**G**) with arrow pointing to abutting *Mab-eve* and *Mab-doc* expression domains. (**H**, **I**) *Mab-zen* and *Mab-eve* expression in early gastrula control embryo (**H**, enlargement **H'**) and following *Mab-dpp* knockdown after 50% blastoderm cellularization (**I**). Arrows, gap between the *Mab-eve* and *Mab-zen* domains (**H'**) that is suppressed in the knockdown embryo (**I**). (**J**--**L**) *Mab-egr* expression at germ band extension in wild-type embryo (**J**), and after *Mab-dpp* knockdown (**K**) or *Mab-dpp* overexpression (**L**) after 50% blastoderm cellularization.**DOI:** [http://dx.doi.org/10.7554/eLife.20894.003](10.7554/eLife.20894.003)10.7554/eLife.20894.004Figure 2---figure supplement 1.Expression of *Mab-doc2.*(**A**, **B**) *Mab-doc2* expression at early gastrulation (**A**) and the extended germ band stage (**B**). (**C**) Maximum likelihood gene tree based on full-length Doc protein homologues. Aae (*Aedes aegypti*), Aga (*Anopheles gambiae*), Mab (*Megaselia abdita*), Dme (*Drosophila melanogaster*), Dps (*Drosophila pseudoobscura*), Dgr (*Drosophila grimshawi*). Bootstrap values, based on 1000 replicas, are shown. (**A**) Dorsal views with anterior left. (**B**) Lateral views with dorsal up and anterior left.**DOI:** [http://dx.doi.org/10.7554/eLife.20894.004](10.7554/eLife.20894.004)10.7554/eLife.20894.005Figure 2---figure supplement 2.Time course of *Mab-zen*, *Mab-doc* and *Mab-eve* expression.(**A**--**C**) *Mab-zen*, *Mab-doc* and *Mab-eve* expression in *Megaselia* embryos with the second panel showing enlarged view near the posterior *Mab-eve* strips, followed by single channel images of DAPI, *Mab-eve*, *Mab-doc*, and *Mab-zen* in successive panels at early blastoderm (**A**), late blastoderm (**B**) and early gastrulation (**C**) stages, indicating amnion specification occurs at early gastrulation. Dorsal views with anterior left.**DOI:** [http://dx.doi.org/10.7554/eLife.20894.005](10.7554/eLife.20894.005)10.7554/eLife.20894.006Figure 2---figure supplement 3..Expression of *Mab-egr.*(**A**--**I**) *Mab-egr* expression in *Megaselia* embryos before blastoderm formation (**A**), during blastoderm cellularization (**B**), and at cellular blastoderm (**C**), early gastrulation (**D**), early and late germ band extension (**E**, **F**), germ band retraction (**G**) and dorsal closure stages (**H**, **I**). (**J**) *Mab-egr* and *Mab-zen* expression in embryos during germ band extension. (**A**--**E**, **I**) Dorsal views with anterior left. (**F**--**H**, **J**) Lateral views with dorsal up and anterior left.**DOI:** [http://dx.doi.org/10.7554/eLife.20894.006](10.7554/eLife.20894.006)10.7554/eLife.20894.007Figure 2---figure supplement 4.Overexpression of *Mab-eve* represses *Mab-zen* expression.(**A**, **B**) Two examples of *Mab-zen* and *Mab-eve* expression at early gastrulation after *Mab-eve* overexpression. Dorsal views with anterior left.**DOI:** [http://dx.doi.org/10.7554/eLife.20894.007](10.7554/eLife.20894.007)

To test the hypothesis that temporally distinct BMP signaling sequentially specifies the two extraembryonic membranes, we decreased BMP signaling during gastrulation by *Mab-dpp* knockdown after 50% blastoderm cellularization and monitored the expression of *Mab-eve*. Knockdown of *Mab-dpp* by injection of double stranded RNA (dsRNA) at the early blastoderm stage completely suppresses both serosa and amnion specification and results in the circumferential expression of *Mab-eve* ([@bib23]). In contrast, in all 13 late *Mab-dpp* knockdown embryos fixed during early gastrulation, the expression of *Mab-zen* was not affected; however, in five embryos the repression of *Mab-eve* in the amnion anlage was incomplete ([Figure 2H--I](#fig2){ref-type="fig"}). Late *Mab-dpp* knockdown reduced *Mab-egr* expression in a majority of stage 11/12 embryos (55%, n = 40) whereas late ectopic *Mab-dpp* expression caused an expansion of the *Mab-egr* domain in at least 35% of the embryos (n = 57) ([Figure 2J--L](#fig2){ref-type="fig"}). Taken together, these data provide evidence that BMP signaling during gastrulation is necessary and sufficient for amnion specification.

*Mab-doc* promotes amnion development by elevating BMP signaling in the amnion anlage at the onset of gastrulation {#s2-2}
------------------------------------------------------------------------------------------------------------------

In *Drosophila*, both BMP signaling and *zen* are necessary at the blastoderm stage for the expression of the three *doc* paralogs and *hnt* in the amnioserosa anlage, although the essential function of these genes in amnioserosa maintenance becomes apparent only after gastrulation ([@bib35]; [@bib24]). However, in *Megaselia*, BMP signaling activates *Mab*-*doc* and *Mab-hnt* independently from *Mab-zen* ([Figure 3---figure supplement 1A--I](#fig3s1){ref-type="fig"}), suggesting these genes could play a role in amnion specification. Following knockdown of *Mab-doc*/*doc2* or *Mab-hnt* activity by RNAi, we observed confluent expression domains of *Mab-zen* and *Mab-eve* during early gastrulation (4/9 and 5/11 embryos, respectively; [Figure 3A--C](#fig3){ref-type="fig"}), and a decrease in *Mab-egr* expression at stage 11/12 ([Figure 3D--F](#fig3){ref-type="fig"}). Knockdown of the activities of all three genes eliminated *Mab-egr* expression in germ-band extended embryos ([Figure 3D](#fig3){ref-type="fig"}), indicating that *Mab-doc/doc2* and *Mab-hnt* together are essential for amnion specification in *Megaselia*. Conversely, overexpression of *Mab-doc* or *Mab-hnt* induced ectopic amnion, as evidenced by an enlargement of the *Mab-egr* domain at stage 11/12 ([Figure 3G](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1J--L](#fig3s1){ref-type="fig"}). Overexpression of *Mab-doc* could bypass the requirement for *Mab-hnt*, while overexpression of *Mab-hnt* could not bypass the requirement for *Mab-doc* ([Figure 3---figure supplement 1M--N](#fig3s1){ref-type="fig"}), consistent with the hypothesis that *Mab-doc* and *Mab-hnt* share a common target necessary for amnion formation that is primarily dependent upon *doc* activity.10.7554/eLife.20894.008Figure 3.*Mab-doc* and *Mab-hnt* elevate BMP signaling to specify amnion in *Megaselia*.(**A**--**C**) *Mab-zen* and *Mab-eve* expression in early gastrula control embryo (**A**) and after *Mab-doc*/*doc2* knockdown (**B**) or *Mab-hnt* knockdown (**C**). Arrows, gap between the *Mab-eve* and *Mab-zen* domains (**A**) that is suppressed in the knockdown embryos (**B, C**). (**D**--**F**) Bar chart (**D**) quantifying the reduction of *Mab-egr* expression at stage 11/12 after *Mab-hnt* and/or *Mab-doc/doc2* knockdown, and representative embryos of moderately reduced (yellow, **E**), or severely reduced (red, **F**) phenotypes. (**G**--**I**) *Mab-egr* expression at germ band extension following *Mab-doc* overexpression (**G**), *Mab-doc* overexpression and *Mab-dpp* knockdown (**H**), and *Mab-dpp* overexpression and *Mab-doc*/*doc2* knockdown (**I**). (**J**--**L**) Mean and shaded standard deviation of pMad intensities in control injected embryos (blue) and in *Mab-doc/doc2* knockdown embryos (red) at the cellular blastoderm stage (n = 10, control n = 10) (**J**), at early gastrulation (n = 11, control n = 11) (**K**), and in *Mab-zen* knockdown embryos (red) at early gastrulation (n = 10, control n = 17) (**L**) with representative embryos stained for pMad underneath each plot.**DOI:** [http://dx.doi.org/10.7554/eLife.20894.008](10.7554/eLife.20894.008)10.7554/eLife.20894.009Figure 3---figure supplement 1.Function and regulation of *Mab-doc* and *Mab-hnt.*(**A**--**D**) *Mab-zen* expression in control embryo (**A**), and *Mab-zen* (**B**), *Mab-doc* (**C**) and *Mab-hnt* (**D**) expression at early gastrulation following *Mab-zen* knockdown. (**E**, **F**) *Mab-hnt* and *Mab-doc* expression at early gastrulation following *Mab-doc/doc2* knockdown (**E**) or *Mab-hnt* knockdown (**F**). (**G**, **H**) *Mab-doc* expression at early gastrulation in wild type (**G**) and after *Mab-dpp* knockdown (**H**). (**I**) *Mab-hnt* expression at early gastrulation following *Mab-dpp* knockdown (image from M. Rafiqi). (**J**) *Mab-egr* and *Mab-zen* expression at stage 11/12 following *Mab-doc* overexpression. (**K**--**N**) *Mab-egr* expression at stage 11/12 in wild type (**K**), following *Mab-hnt* overexpression (**L**), following *Mab-hnt* overexpression and *Mab-doc/doc2* knockdown (**M**) or *Mab-doc* overexpression and *Mab-hnt* knockdown (**N**). (**O**) Bar chart showing the percentages of embryos with normal (green), moderately (yellow) or severely reduced (red) *Mab-egr* expression at stage 11/12 following *Mab-doc/doc2* knockdown or *Mab-doc/doc2/zen* knockdown. (**A**--**I**) Dorsal views with anterior left. (**J**--**N**) Lateral views with dorsal up and anterior left.**DOI:** [http://dx.doi.org/10.7554/eLife.20894.009](10.7554/eLife.20894.009)

The activities of *Mab-doc* and *Mab-hnt* could promote the amnion formation in an instructive manner, by activating the amnion gene network of *Megaselia*, or they might promote the amnion formation in a permissive manner, e.g., by elevating BMP signaling. Overexpression of *Mab-doc* in *Mab-dpp* knockdown embryos did not induce any expression of *Mab-egr* in stage 11/12 embryos (n = 44) ([Figure 3H](#fig3){ref-type="fig"}). Conversely, overexpression of *Mab-dpp* in *Mab-doc/doc2* knockdown embryos resulted in ectopic expression of *Mab-egr* at stage 11/12 (36%, n = 47) ([Figure 3I](#fig3){ref-type="fig"}). Thus, BMP signaling is sufficient to direct the expression of amnion specific genes in the absence of *Mab-doc/doc2* activity. To confirm that this result was not due to an excessive non-physiological level of Mab-Dpp produced by the injected mRNA, we asked whether the endogenous level of BMP signaling at the dorsal midline in the blastoderm embryo would be sufficient to specify amnion in the absence of both *Mab-doc/doc2* and the serosal determinant *Mab-zen*. Knockdown of *Mab-zen* partially restored amnion in *Mab-doc/doc2* knockdown embryos ([Figure 3---figure supplement 1O](#fig3s1){ref-type="fig"}). Taken together, these data suggest *Mab-doc* promotes amnion formation permissively.

To directly test whether *Mab-doc* activity elevates BMP signaling, we quantified the intensity of pMad staining in embryos after *Mab-doc/doc2* knockdown. While *Mab-doc/doc2* knockdown had little effect on pMad levels during the late blastoderm stage compared to control embryos (Wilcoxon rank sum test, p=0.3697; [Figure 3J](#fig3){ref-type="fig"}), in early gastrula stage embryos, knockdown of *Mab-doc/doc2* resulted in significantly reduced pMad levels compared to control embryos (Wilcoxon rank sum test, p=0.01165; [Figure 3K](#fig3){ref-type="fig"}). In contrast, knockdown of *Mab-zen* did not alter the average level of pMad at the beginning of gastrulation (Wilcoxon rank sum test, p=0.2367; [Figure 3L](#fig3){ref-type="fig"}). The observation that *Mab-doc/doc2* is dispensable for amnion cell fate specification but necessary for wild-type levels of BMP signaling at the early gastrula stage strongly support the model that amnion formation is driven by a *Mab-doc*-dependent elevation of BMP signaling in the amnion anlage at the onset of gastrulation.

*Mab-doc*-dependent control of *Mab-egr* expression contributes to a positive feedback circuit that promotes BMP signaling during gastrulation {#s2-3}
----------------------------------------------------------------------------------------------------------------------------------------------

We then explored the mechanism by which *Mab-doc* promotes BMP signaling at the gastrula stage. Embryos injected centrally with *Mab-doc* mRNA displayed a local expansion of the pMad domain during gastrulation (15/15) coupled with the frequent depletion of endogenous pMad in adjacent regions (12/15) ([Figure 4A](#fig4){ref-type="fig"}). This result parallels a phenotype observed in *Drosophila* where injection of mRNA encoding activated BMP receptors into the blastoderm embryo causes an increase in BMP ligand-receptor interactions, coupled with a decrease in BMP ligand-receptor binding in nearby regions ([@bib32]). These data indicate that a positive feedback circuit downstream of BMP signaling increases local receptor-ligand interactions, and that, due to a limiting amount of BMP ligand, ligand-receptor interactions decrease in nearby regions. Conversely, *Megaselia* embryos injected with *Mab-zen* mRNA (n = 11) had a similar pMad domain to injected control embryos (n = 12) and developed a reduced or abnormal amnion (44/51) ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). These results suggest *Mab-doc*, but not *Mab-zen*, locally activates a positive feedback circuit in the *Megaselia* embryo, where BMP ligands are limiting.10.7554/eLife.20894.010Figure 4.*Mab-egr* is downstream of *Mab-doc* and promotes BMP signaling.(**A**, **B**) pMad staining following *Mab-doc* overexpression (**A**) or *Mab-doc* overexpression and *Mab-egr* knockdown (**B**). The asterisk marks site of endogenous pMad depletion. (**C**) Mean intensity and standard deviation of pMad staining in control injected embryos (blue, n = 10) and *Mab-egr* knockdown embryos (red, n = 9) at early gastrulation with representative embryos stained for pMad underneath the plot. (**D**) *Mab-zen* and *Mab-eve* expression at early gastrulation after *Mab-egr* knockdown with arrow indicating suppressed gap between the *Mab-eve* and *Mab-zen* domains. (**E**--**H**) *Mab-egr* expression in wild type (**E**), *Mab-dpp* knockdown (**F**), *Mab-doc/doc2* knockdown (**G**), and *Mab-zen* knockdown (**H**) embryos at early gastrulation. (**I**) *Mab-egr* expression in a *Mab-zen* knockdown embryo after germ band extension. (**J**) BMP gene regulatory networks in *Megaselia abdita* and *Drosophila melanogaster*.**DOI:** [http://dx.doi.org/10.7554/eLife.20894.010](10.7554/eLife.20894.010)10.7554/eLife.20894.011Figure 4---figure supplement 1.Effect of *Mab-zen* overexpression on BMP signaling.(**A**, **B**) pMad staining at early gastrulation in control (**A**) and after *Mab-zen* overexpression (**B**). (**C**, **D**) *Mab-egr* expression at late germband extension after *Mab-zen* overexpression. The majority of embryos showed reduced *Mab-egr* expression (37/51) (**C**) while a minority of embryos showed either expanded *Mab-egr* expression (7/51) (**D**), possibly as a consequence of premature serosa-amnion disruption, or were indistinguishable from wild type (7/51) (not shown). (**A**, **B**) Dorsal views with anterior left. (**C**, **D**) Lateral views with dorsal up and anterior left.**DOI:** [http://dx.doi.org/10.7554/eLife.20894.011](10.7554/eLife.20894.011)10.7554/eLife.20894.012Figure 4---figure supplement 2.Efficiency of *Mab-egr* RNAi.(**A**--**D**) *Mab-egr* expression in control (**A, B**) and *Mab-egr* knockdown embryos (**C, D**) at early gastrulation (**A, C**) and during germ band extension (**B, D**). Dorsal views with anterior left.**DOI:** [http://dx.doi.org/10.7554/eLife.20894.012](10.7554/eLife.20894.012)10.7554/eLife.20894.013Figure 4---figure supplement 3.Expression profile of *Mab-cv-2*.(**A**--**D**) *Mab-cv-2* expression in *Megaselia* embryos at early gastrulation (**A**), late gastrulation (**B**), during germ band retraction (**C**), and at the end of germ band retraction (**D**). (**A**, **B**, **C**) Dorsal views with anterior left. (**A'**, **B'**, **C'**, **D**, **D'**) Lateral views with dorsal up and anterior left.**DOI:** [http://dx.doi.org/10.7554/eLife.20894.013](10.7554/eLife.20894.013)10.7554/eLife.20894.014Figure 4---figure supplement 4.*Mab-cv-2* promotes amnion specification.(**A**, **B**) *Mab-zen* and *Mab-eve* expression at early gastrulation with some embryos showing reduced amnion after *Mab-cv-2* knockdown (3/9) (**A**), and after *Mab-egr/cv-2* knockdown (2/9) (**B**). Dorsal views with anterior left.**DOI:** [http://dx.doi.org/10.7554/eLife.20894.014](10.7554/eLife.20894.014)10.7554/eLife.20894.015Figure 4---figure supplement 5.Regulation of *Mab-cv-2* is largely independent of *Mab-doc/doc2*.(**A**, **B**) *Mab-cv-2* expression at early gastrulation in control (**A**) and after *Mab-doc/doc2* knockdown (**B**). Dorsal views with anterior left.**DOI:** [http://dx.doi.org/10.7554/eLife.20894.015](10.7554/eLife.20894.015)

Recent experiments in *Drosophila* identified *egr* activity as a component of the positive feedback circuit ([@bib9]). To determine whether *Mab-egr* could be a component of a positive feedback circuit in *Megaselia*, we asked whether knockdown of *Mab-egr* could modify the phenotype caused by injection of *Mab-doc* mRNA. While the pMad domain in all *Mab-doc* injected embryos was locally expanded (14/14) ([Figure 4B](#fig4){ref-type="fig"}), only a few embryos (2/14) displayed a depletion of endogenous pMad in adjacent regions. These data indicate that *Mab-egr* increases the ability of cells overexpressing *Mab-doc* to compete for BMP ligands during early gastrulation.

In *Drosophila*, loss of *egr* reduces intensity of pMad staining by 50% ([@bib9]). Similarly, we found that, at the onset of gastrulation, pMad levels in *Mab-egr* knockdown embryos were reduced by about 50% on average (Wilcoxon rank sum test, p=0.00381) ([Figure 4C](#fig4){ref-type="fig"} and [Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}). Moreover, confluent expression domains of *Mab-eve* and *Mab-zen* could be observed in such embryos (3/10) ([Figure 4D](#fig4){ref-type="fig"}). As *Mab-egr* expression extends to the edge of the gastrulating germ rudiment, these observations suggest that *Mab-egr* promotes amnion specification downstream of *Mab-doc/doc2* by elevating BMP signaling during gastrulation in prospective amnion cells.

The pMad gradients of *Mab-egr* RNAi embryos were on average slightly broader than in *Mab-doc/doc2* RNAi embryos ([Figures 3K](#fig3){ref-type="fig"} and [4C](#fig4){ref-type="fig"}), suggesting that *Mab-doc/doc2* might control more than one gene with a role in shaping the BMP gradient, similar to *Drosophila* where the BMP-dependent feedback circuit appears to involve more genes than just *egr* ([@bib9]). As a potential second *Mab-doc/doc2* target we examined the *Megaselia* ortholog of *cv-2* ([Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}), which encodes an extracellular, context- and concentration-dependent modulator of BMP signaling ([@bib4]; [@bib27]). However, although *Mab-cv-2* likely also promotes BMP signaling in *Megaselia* ([Figure 4---figure supplement 4](#fig4s4){ref-type="fig"}), it appears to function independently of the *Mab-doc/doc2*-dependent feedback loop ([Figure 4---figure supplement 5](#fig4s5){ref-type="fig"}).

Lastly, we examined the regulation of *Mab-egr* expression. In *Drosophila*, *egr* expression begins at the syncytial blastoderm stage under the control of both BMP signaling and *zen,* whereas in *Megaselia*, *Mab-egr* expression begins at the onset of gastrulation. In *Mab-dpp* knockdown embryos, *Mab-egr* expression was completely absent ([Figure 4E--F](#fig4){ref-type="fig"}). In *Mab-doc/doc2* knockdown embryos, *Mab-egr* expression was greatly reduced ([Figure 4G](#fig4){ref-type="fig"}). *Mab-doc/doc2/hnt* triple knockdown did not further reduce *Mab-egr* expression during gastrulation (not shown). *Mab-zen* knockdown embryos displayed only a slight reduction in *Mab-egr* expression during gastrulation; however, at germ band extension, *Mab-zen* knockdown embryos displayed an increase in the number of *Mab-egr* expressing cells due to the transformation of serosa into amnion ([Figure 4H--I](#fig4){ref-type="fig"}). Thus, in *Megaselia*, *Mab-egr* is primarily under the control of *Mab-doc*, not *Mab-zen*.

Conclusions {#s2-4}
-----------

While previous work has demonstrated that BMP gradients can form and be stabilized through molecular feedback circuits ([@bib2]), we have shown here that positive feedback circuits can also be an important target in the evolution of body plans. Specifically, the distinct BMP gradients of *Megaselia* and *Drosophila*, which result in the specification of distinct extraembryonic tissue complements, are the result of spatiotemporal changes in an *egr*-dependent positive feedback circuit ([Figure 4J](#fig4){ref-type="fig"}).

Given that *Megaselia* has retained distinct serosa and amnion tissues, the function of the BMP gradient in this species might be similar to the ancestral condition in higher flies. What changes to the underlying genetic network during evolution would have been necessary to transform the shape of the *Megaselia* BMP gradient into that seen in *Drosophila*? In blastoderm embryos of *Megaselia*, the BMP gradient establishes the expression of *Mab-zen* in prospective serosa tissue, and *Mab-doc/doc2* and *Mab-hnt* in prospective serosa and amnion tissues. While this patterning phase is not sufficient to differentiate between serosa and amnion tissue, it sets the stage for *Mab-doc/doc2*-dependent *Mab-egr* expression during gastrulation. The *Drosophila* gene network that regulates *egr* expression differs at least in two ways. First, *doc* (along with *hnt*) is expressed downstream of *zen*. Conceptually, this regulatory difference is sufficient to explain the difference of *egr* expression between the two species during gastrulation, and hence also the difference in BMP signaling and tissue specification. We therefore propose that this change led the evolutionary transition. Once *doc* was downstream of *zen*, the latter might have gradually gained control over *egr*. This scenario is consistent with our observation that even in *Megaselia*, *Mab-zen* slightly promotes *Mab-egr* expression. Second, *Drosophila* acquired a BMP-independent *zen* expression domain in the syncytial blastoderm, which is not observed in other dipterans ([@bib10]; [@bib20]). The acquisition of this early *zen* domain could have promoted *egr* expression in the blastoderm of *Drosophila*, where *egr* is part of a *zen*-dependent network that confers robustness to the BMP gradient ([@bib9]).

Our data suggest that the ancestral function of the positive feedback circuit was to promote amnion specification through BMP signaling. While the identity of regulatory factors of the positive feedback circuit may be evolutionarily labile (in Tribolium *doc* and *hnt* appear to be dispensable for amnion specification \[[@bib12]\]), we propose that the mechanism of amnion specification through feedback-driven BMP signaling dynamics applies to a wide range of insects, because in Tribolium the pMad domain also gradually shifts to become elevated in the presumptive amnion during early gastrula stages ([@bib31]; [@bib18]). The principle of evolving tissue complexity through changes in positive feedback circuits of morphogen gradients has not yet been documented in other developmental contexts, but it may also apply to unrelated traits, such as eyespots on butterfly wings ([@bib17]).

Materials and methods {#s3}
=====================

dsRNA and mRNA synthesis, injections and fixation {#s3-1}
-------------------------------------------------

RNAi was performed as described ([@bib20], [@bib21]). In negative controls, embryos were injected with dsRNA against the *huckebein* homolog from another fly species, *Eba-hkb* ([@bib15]). dsRNAs for *Eba-hkb*, *Mab-hnt*, *Mab-zen,* and *Mab-dpp* were prepared as described ([@bib20]; [@bib15]; [@bib21]). The following primers were used to synthesize dsRNA against *Mab-doc*: (5'-CCAAGCCTTC[TAATACGACTCACTATAGGGAGA]{.ul}GACGAGGATGGCGAGTACTG-3' and 5'-CAGAGATGCA[TAATACGACTCACTATAGGGAGA]{.ul}GTTCCCACCAATGGTTGTGC-3'), *Mab-doc2*: (5'-CCAAGCCTTC[TAATACGACTCACTATAGGGAGA]{.ul}TGAGTGGTGTGGATATCGCG-3' and 5'-CAGAGATGCA[TAATACGACTCACTATAGGGAGA]{.ul}AGCAAGGACAGTGTGACCAT-3'), *Mab-cv-2*: (5'-CAGAGATGCA[TAATACGACTCACTATAGGGAGA]{.ul}ACGGCGCAAATCCGACTGTTGT-3' and 5'-CCAAGCCTTC[TAATACGACTCACTATAGGGAGA]{.ul}AACGCAGAGTGGAGCCGCTT-3'), and *Mab-egr*: (5'-CGCCGCGGTCTACATCACTGTT-3' and 5'-CGCCGCGGTCTACATCACTGTT-3'). T7 promoters are underlined. To create the template for capped *Mab-doc, Mab-hnt, Mab-dpp,* and *Mab-eve* mRNAs, complete ORFs were PCR-amplified from embryonic cDNA using primers with attB recombination sites attached at the 5' ends. The following primers were used: *Mab-hnt* (5'-GGGG[ACAAGTTTGTACAAAAAAGCAGGCT]{.ul}ACCATGCTTCATGCAACCAACC-3' and 5'-GGGG[ACCACTTTGTACAAGAAAGCTGGGT]{.ul}CTACTTCTCAACACCCAAGAACTTG-3'), *Mab-doc* (5'-GGGG[ACAAGTTTGTACAAAAAAGCAGGCT]{.ul}AAAATGATTACCATGAATGAATTAGTG-3' and 5'-GGGG[ACCACTTTGTACAAGAAAGCTGGGT]{.ul}CTAACATTGCGCAACACCCAAAA-3'), *Mab-dpp* (5'-GGGG[ACAAGTTTGTACAAAAAAGCAGGCT]{.ul}AAAATGCGCGCATGGCTT-3' and 5'-GGGG[ACCACTTTGTACAAGAAAGCTGGGT]{.ul}TCATCGACATCCACATCCAAC-3'), and *Mab-eve* (5'-GGGG[ACAAGTTTGTACAAAAAAGCAGGCT]{.ul}AAAATGCAAGGATACAGAAACTACA-3' and 5'-GGGG[ACCACTTTGTACAAGAAAGCTGGGT]{.ul}TTAGGCCTCACTCTCTGTCTT-3'). The attB recombination sites are underlined. The ORFs were cloned into a destination vector which was modified from the pSP35T ([@bib1]) using Gateway Cloning (Life Technology). Capped mRNAs were prepared using SP6 polymerase with the mMessage mMachine Kit (Ambion). Sequence information of *Mab-doc2* (KY302676), *Mab-egr *(KY302677), and *Mab-cv-2 *(KY302678) is provided in Genbank. For microinjection, embryos were collected and aligned on a glass slide along a 0.2 mm glass capillary, briefly desiccated, and covered with halocarbon oil (Sigma H773) at room temperature as described ([@bib22]). Stages of the embryos were defined according to ([@bib34]). Embryos were injected before the syncytial blastoderm stage (\~1:30--2:30 hr at 18°C after egg deposition) unless otherwise specified. Injected embryos were then heat fixed and manually devitellinized as described ([@bib22]) before in situ hybridization and immunostaining.

RNA in situ hybridization, immunohistochemistry and image analysis {#s3-2}
------------------------------------------------------------------

RNA probes were labeled with digoxigenin (*Mab-egr, Mab-dpp*), fluorescein (*Mab-doc*, *Mab-doc2, Mab-zen* and *Mab-hnt*) and biotin (*Mab-eve*) as described ([@bib29]; [@bib14]). Probe templates for *Mab-eve*, *Mab-zen*, and *Mab-hnt* were synthesized as described ([@bib3]; [@bib20], [@bib21]). Other probes were synthesized from PCR templates obtained from an embryonic cDNA library using the following primers: *Mab-egr*5' (5'-CCAAGCCTTC[TAATACGACTCACTATAGGGAGA]{.ul}TGAGCTGCTGCCAGAGCGTT-3' and 5'-CAGAGATGCA[ATTAACCCTCACTAAAGGGAGA]{.ul}TGTGCATTTTGTGATTATTGAAAGT-3'), *Mab-egr3'* (5'-CCAAGCCTTC[TAATACGACTCACTATAGGGAGA]{.ul}AACTATGAGACAAATACTTAACGGA-3' and 5'-CAGAGATGCA[ATTAACCCTCACTAAAGGGAGA]{.ul}TCGAGCGATTGACGTCTCAGT-3'), *Mab-doc* (5'-CCAAGCCTTC[TAATACGACTCACTATAGGGAGA]{.ul}GACGAGGATGGCGAGTACTG-3' and 5'-CAGAGATGCA[ATTAACCCTCACTAAAGGGAGA]{.ul}GTTCCCACCAATGGTTGTGC-3'), *Mab-doc2* (5'-CCAAGCCTTC[ATTAACCCTCACTAAAGGGAGA]{.ul}TGAGTGGTGTGGATATCGCG-3' and 5'-CCAAGCCTTC[TAATACGACTCACTATAGGGAGA]{.ul}TGAGTGGTGTGGATATCGCG-3'), *Mab-cv-2* (5'-CAGAGATGCA[ATTAACCCTCACTAAAGGGAGA]{.ul}ACGGCGCAAATCCGACTGTTGT-3' and 5'-CCAAGCCTTC[TAATACGACTCACTATAGGGAGA]{.ul}AACGCAGAGTGGAGCCGCTT-3') and the synthesis of other probes were previously described ([@bib20], [@bib21]). T3 and T7 promoters are underlined in the forward and reverse primers, respectively. The following procedures for RNA in situ hybridization and immunostaining were done as described ([@bib23]). For RNA in situ hybridization, *Megaselia* embryos were heat fixed, while for immunostaining, they were fixed by formaldehyde except for quantification (see below). pMad was detected with a rabbit monoclonal antibody against Smad3 phosphorylated on Serine 423 and Serine 425 (Epitomics, Cat\# 1880--1) at 1:250 dilution. For two-color fluorescent in situ hybridization, confocal scans were done with a Zeiss LSM510 laser-scanning microscope. All subsequent image quantification and analysis of confocal micrographs were done in ImageJ ([@bib26]). To quantify pMad staining intensity, embryos were stained with pMad as described ([@bib23]) after a modified fixation protocol. To preserve better morphology for quantification, heat fix was used instead of formaldehyde. The embryos were treated with a boiling solution of 0.7% NaCl and 0.05% Triton X-100 followed by a heptane and methanol devitellinization step. Postfixation was done with 5% formaldehyde in a 3:1 mixture of phosphate buffered saline (PBT; 137 mM NaCl, 2.7 mM KCl, 10 mM Na~2~HPO~4~, 2 mM KH~2~PO~4~, 0.1% Triton X-100 pH 7.4) and methanol. This was followed by a second heptane and methanol devitellinization step. Embryos at early gastrulation were staged after the initiation of cephalic furrow and before the dorsal-most point of the proctodeum reached 20% of total egg length. The quantification of pMad staining in injected *Megaselia* embryos followed the *Drosophila* protocol ([@bib9]). To compare whether there was a significant reduction of pMad intensity in *Mab-egr* RNAi compared to wild type, a Wilcoxon rank sum test was performed in R \[R Core Team (2012). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. <http://www.R-project.org>\].

Gene trees {#s3-3}
----------

Amino acid sequences of *Dorsocross* homologs in different species with the following reference numbers were retrieved (*Aedes aegypti; Aae-docA XP_001648597.1* and *Aae-docB XP_001663692.1*), (*Anopheles gambiae; Aga-docA XP_315924.3* and *Aga-docB EAA11871.5*), (*Drosophila melanogaster; Doc1* AAF50328.2, *Doc2* AAF50329.1 and *Doc3* AAF50331.1), (*Drosophila pseudoobscura; Dps-Doc1 EAL31211.1, Dps-Doc2 EAL31212.2,* and *Dps-Doc3 EAL31210.1*), (*Drosophila grimshawi; Dgr-Doc1 EDV96918.1, Dgr-Doc2 EDV96917.1* and *Dgr-Doc3 EDV96915.1*). Full-length protein alignments were created using the MUSCLE program with default parameters ([@bib8]). The best amino acid substitution model was estimated using AIC in ProtTest 3 ([@bib6]) and the LG model was chosen. Maximum likelihood trees were calculated using PhyML 3 ([@bib5]). Bootstrap values were based on 1000 replicas.
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Thank you for submitting your article \"Functional evolution of a morphogenetic gradient\" for consideration by *eLife*. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by Marianne Bronner as the Senior Editor and Reviewing Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

Kwan et al. investigate BMP patterning in embryos of the fly *Megaselia* and compare this with known mechanisms acting in *Drosophila*. Data support the view that evolutionary changes are responsible for differences in tissue specification found within these two fly species. In *Megaselia*, serosa and amnion form as two distinct tissues, whereas the aminoserosa forms as one merged tissue in *Drosophila*. The data, composed mostly of RNAi, ectopic expression, and colocalization of BMP ligands and target genes, makes a compelling case for differences in feedback control of BMP signaling between these two species as causative for these tissue differences. Specifically, the data suggest that the gene networks acting in these two fly species have changed with regard to the regulation of the gene *eiger (egr*). In *Drosophila*, prior published studies have demonstrated *egr* is a positive regulator of BMP signaling, acting downstream of *decapentaplegic (dpp*) and *zerknüllt (zen*) genes. Here, the authors show that in *Megaselia, egr* also acts downstream of *dpp* but, in contrast to the case in *Drosophila*, that in *Megaselia egr* is not regulated by *zen* (or rather, it has a minor role). Instead, in *Megaselia, egr* is regulated by the *dorsocross* genes (*doc/doc2*). This change in regulation of *egr* is proposed as the mechanism by which amnion regulation (through *doc* genes and *hnt*) was separated from serosa regulation (mediated by *zen*).

The results are interesting, novel and well controlled and the manuscript is well written. Some additional experiments are required as outlined below.

Essential revisions:

1\) Why does *Mab-egr* RNAi reduce pMad levels uniformly but not the width of the pMad stripe; whereas, *Mab-doc* genes RNAi reduces pMad levels and the width of the stripe?

Essentially, pMad within the amnion domain of *Mab-egr* RNAi embryos appears \"normal\" (stripe is just as wide) whereas in the *Mab-doc* mutants the pMad stripe is thinner. Could this relate to a role of *Mab-doc* genes in regulating a *Mab-cv-2*? Or other target genes besides *egr*?

2\) Is there *cv-2* in *Megaselia* and does it also act together with *Mab-egr* to support positive feedback? The authors may not want to address *cv-2* experimentally, but at least a sentence or two should be added to the text to put the current study in context of what\'s known in *Drosophila*.

3\) How certain are the authors that *Mab-zen* RNAi is working? (e.g. [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}, panels A-C). Is *zen* expression lost at st 5 and st 6? Can *Mab-zen* RNAi lead to efficient decrease in levels earlier to support results of [Figure 2H, I](#fig2){ref-type="fig"} and [Figure 3L](#fig3){ref-type="fig"}, for example?

4\) On the flip side, how certain is it that *Mab-zen* levels are not affected upon *Mab-dpp* RNAi? Levels in [Figure 2I](#fig2){ref-type="fig"} do appear reduced relative to [Figure 2H](#fig2){ref-type="fig"}. Can *zen* levels be quantified? And possibly compared to *zen* levels upon *Mab-zen* RNAi.
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Author response

*Essential revisions:*

*1) Why does Mab-egr RNAi reduce pMad levels uniformly but not the width of the pMad stripe; whereas, Mab-doc genes RNAi reduces pMad levels and the width of the stripe?*

*Essentially, pMad within the amnion domain of Mab-egr RNAi embryos appears \"normal\" (stripe is just as wide) whereas in the Mab-doc mutants the pMad stripe is thinner. Could this relate to a role of Mab-doc genes in regulating a Mab-cv-2? Or other target genes besides egr?*

*2) Is there cv-2 in Megaselia and does it also act together with Mab-egr to support positive feedback? The authors may not want to address cv-2 experimentally, but at least a sentence or two should be added to the text to put the current study in context of what\'s known in Drosophila.*

We agree that BMP signaling and *Mab-doc/doc2* activity together could regulate more than one gene with a role in shaping the BMP gradient and thank the reviewers for pointing this out. We address this issue in a new paragraph (--subsection "*Mab-doc*-dependent control of *Mab-egr* expression contributes to a positive feedback circuit that promotes BMP signaling during gastrulation", fourth paragraph) and added a brief description of *cv-2* experiments in *Megaselia* to the revised manuscript ([Figure 4---figure supplements 3](#fig4s3){ref-type="fig"}, [4](#fig4s4){ref-type="fig"} and [5](#fig4s5){ref-type="fig"}).

For *Drosophila*, Gavin-Smyth et al. (2013) found that the reduction of BMP signaling was less severe in *egr* deficient embryos than in *Medea* deficient embryos that completely lack BMP-dependent positive feedback, suggesting that *egr* is not the only target of BMP signaling involved in the feedback process. Gavin-Smyth et al. (2013) also presented an analysis of the *cv-2* phenotype. In *Drosophila*, the initial expression of *cv-2* is not under BMP control but under the control of *zen*, which is expressed independently of BMP signaling in stage 5 embryos; therefore Gavin-Smyth et al. did not consider it part of the feedback circuitry in *Drosophila*. They also reported that loss of *cv-2* causes an elevation of BMP signaling, indicating it does not simply act as a component in a positive feedback circuit. In the new paragraph of our manuscript, we explicitly acknowledge the possibility of additional BMP/doc target genes acting as feedback components in *Megaselia* and quote the Gavin--Smyth paper for a potential parallel with *Drosophila* where BMP signaling seems to control more than one feedback component.

In *Megaselia, Mab-cv-2* expression is widely expressed from stage 6 onwards, with slightly higher expression dorsally, and was not grossly perturbed by *Mab-doc/doc2* knockdown, suggesting that, like in *Drosophila*, it is not a component of the feedback process. Interestingly, we find that knockdown of *Mab-cv-2* can perturb amnion specification at the beginning of gastrulation, suggesting that *Mab-cv-2* might promote BMP signaling at the beginning of gastrulation, unlike in *Drosophila* where it attenuates BMP signaling. This difference between *Megaselia* and *Drosophila* is not completely surprising because Cv-2 has been shown to act in a context and dose dependent manner to either promote or inhibit BMP signaling. In conclusion, while the only confirmed *Mab-doc/doc2* target remains *Mab-*egr, we have modified the manuscript to take into account the likelihood that there are other target genes.

*3) How certain are the authors that Mab-zen RNAi is working? (e.g. [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}, panels A-C). Is zen expression lost at st 5 and st 6? Can Mab-zen RNAi lead to efficient decrease in levels earlier to support results of [Figure 2H, I](#fig2){ref-type="fig"} and [Figure 3L](#fig3){ref-type="fig"}, for example?*

As we have shown previously, *Mab-zen* RNAi is effective within less than 10 minutes after injection of dsRNA (supplemental Figure 1A in Rafiqi et al. 2010). To clarify this issue, we replaced panels of the original [Figure 3---figure supplement 1A-C](#fig3s1){ref-type="fig"} (showing embryos at stage 8 stained for *Mab-zen, Mab-doc* and *Mab-hnt* following *Mab-zen* RNAi) with four new panels showing representative *Mab-zen* expression patterns at stage 6 in a control-injected embryo (A) and in a *Mab-zen* RNAi embryo (B), in addition to stage-matched *Mab-zen* RNAi embryos stained with *Mab-doc* and *Mab-hnt* probes (C, D). In *Mab-zen* RNAi embryos, only residual punctate *Mab-zen* expression was observed, consistent with high transcriptional activity in the nuclei during gastrulation. In the cytoplasm, *Mab-zen* transcript did not accumulate above a background level, indicating that *Mab-zen* expression is post-transcriptionally knocked down in *Mab-zen* RNAi embryos.

*4) On the flip side, how certain is it that Mab-zen levels are not affected upon Mab-dpp RNAi? Levels in [Figure 2I](#fig2){ref-type="fig"} do appear reduced relative to [Figure 2H](#fig2){ref-type="fig"}. Can zen levels be quantified? And possibly compared to zen levels upon Mab-zen RNAi.*

In the original figure, contrast enhancement differed between the images shown in panels 2H and I. When original pictures of late *Mab-dpp* RNAi embryos were processed in exactly the same way as the controls, *Mab-zen* expression levels were similar between controls and late *Mab-dpp* RNAi embryos (n=6). However, we noticed that the green background caused by the *Mab-eve* probe varied slightly between embryos. In the revised figure, the image shown in 2I was replaced with an image that was subjected to same contrast enhancement that the image shown in 2I.
